Possible progress against Parkinson's and good news for stem cell therapies
Mitomycin-treated embryonic stem cells shows to be a safe and effective therapeutic strategy for Parkinson's disease, reducing symptoms and not generating tumors in mice
2015-04-03
(Press-News.org) Brazilian researchers at D'OR Institute for Research and Education (IDOR) and Federal University of Rio de Janeiro (UFRJ) have taken what they describe as an important step toward using the implantation of stem cell-generated neurons as a treatment for Parkinson's disease. Using an FDA approved substance for treating stomach cancer, Rehen and colleagues were able to grow dopamine-producing neurons derived from embryonic stem cells that remained healthy and functional for as long as 15 months after implantation into mice, restoring motor function without forming tumors.
Parkinson's, which affect as many 10 million people in the world, is caused by a depletion of dopamine-producing neurons in the brain. Current treatments include medications and electrical implants in the brain which causes severe adverse effects over time and fail to prevent disease progression. Several studies have indicated that the transplantation of embryonic stem cells improves motor functions in animal models. However, until now, the procedure has shown to be unsafe, because of the risk of tumors upon transplantation.
To address this issue, the researchers tested for the first time to pre-treat undifferentiated mouse embryonic stem cells with mitomycin C, a drug already prescribed to treat cancer. The substance blocks the DNA replication and prevents the cells to multiply out of control.
The researchers used mice modeled for Parkinson's. The animals were separated in three groups. The first one, the control group, did not receive the stem cell implant. The second one, received the implant of stem cells which were not treated with mitomycin C and the third one received the mitomycin C treated cells.
After the injection of 50,000 untreated stem cells, the animals of the second group showed improvement in motor functions but all of them died between 3 and 7 weeks later. These animals also developed intracerebral tumors. In contrast, animals receiving the treated stem cells showed improvement of Parkinson's symptoms and survived until the end of the observation period of 12 weeks post-transplant with no tumors detected. Four of these mice were monitored for as long as 15 months with no signs of pathology.
Furthermore, the scientists have also shown that treating the stem cells with mitomycin C induced a four-fold increase in the release of dopamine after in vitro differentiation.
"This simple strategy of shortly exposing pluripotent stem cells to an anti-cancer drug turned the transplant safer, by eliminating the risk of tumor formation", says the leader of the study Stevens Rehen, Professor at UFRJ and researcher at IDOR.
The discovery, reported on April in the journal Frontiers in Cellular Neuroscience, could pave the way for researchers and physicians to propose a clinical trial using pluripotent stem cells treated with mitomycin C prior to transplant to treat Parkinson's patients and also other neurodegenerative conditions.
"Our technique with mitomycin C may speed the proposal of clinical trials with pluripotent cells to several human diseases", says Rehen. "It is the first step to make this kind of treatment with stem cells possible".
INFORMATION:
About the IDOR
The D'Or institute of Research is a nonprofit organization which aims to promote scientific and technological progress in healthcare through research and education. IDOR was established in 2010 in Botafogo, Rio de Janeiro, Brazil. Since then, the institute is responsible for designing, planning and overseeing most of the educational and research activities conducted intramurally by its sponsor, one of the most important hospital groups in Brazil, the Rede D'Or São Luiz. Our main areas of research are neurosciences, oncology, intern medicine, intensive medicine and pediatrics.
Details: M. Acquarone, T. Melo, F. G. Meireles Ferreira, J. Brito-Moreira, G. Oliveira, S. Ferreira, N. Castro, F. Tovar-Moll, J. C. Houzel, S. K. Rehen. Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson's disease. Frontiers in Cellular Neuroscience. Available online.
The full article is available here: http://journal.frontiersin.org/article/10.3389/fncel.2015.00097/abstract
ELSE PRESS RELEASES FROM THIS DATE:
2015-04-03
PROVIDENCE, R.I. - Adam C. Levine, M.D., an emergency medicine physician at Rhode Island Hospital and The Miriam Hospital who treated Ebola-infected patients in Liberia last year, used his field experience to create a tool to determine the likelihood that patients presenting with Ebola symptoms will actually carry the virus. His research was published in the Annals of Emergency Medicine today.
Ebola Virus Disease (EVD) has affected 24,000 persons during the current epidemic, which is the largest recorded outbreak of EVD in history. Over 10,000 people have died in West ...
2015-04-03
Scientists use small molecule that suppresses cancer-causing genes in glioblastoma
Nanotechnology crosses blood-brain barrier to reach tumor cells
Approach has potential to silence genes in other cancers and genetic diseases
CHICAGO --- Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor.
While standard chemotherapy drugs damage DNA to stop cancer cells from reproducing, the new method stops the source ...
2015-04-03
ROCHESTER, Minn. -- Recent large-scale genomic analyses have uncovered dozens of common genetic variants that are associated with breast cancer. Each variant, however, contributes only a tiny amount to a person's overall risk of developing the disease.
A Mayo Clinic-led team of international researchers has now combined 77 of these common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer. This factor, known as a polygenic risk score, was built from the genetic data of more than 67,000 ...
2015-04-03
If a time machine was available, would it be right to kill Adolf Hitler when he was still a young Austrian artist to prevent World War II and save millions of lives? Should a police officer torture an alleged bomber to find hidden explosives that could kill many people at a local cafe? When faced with such dilemmas, men are typically more willing to accept harmful actions for the sake of the greater good than women. For example, women would be less likely to support the killing of a young Hitler or torturing a bombing suspect, even if doing so would ultimately save more ...
2015-04-03
HOUGHTON, Mich. (April 3, 2015): Central Appalachian forests have been experiencing the effects of a changing climate for decades, and effects such as more heavy rainfall events, more drought, and more hot days are likely to continue, according to a new vulnerability assessment for the region by the U.S. Forest Service and many partners.
The assessment describes effects of climate change that have already been observed, projected changes in the climate and the landscape, and forest vulnerabilities for nine forest ecosystem types in a 29-million-acre area of Ohio, West ...
2015-04-03
(New York, NY) April 3, 2015 - The scientific community is facing a 'pollution problem' in academic publishing, one that poses a serious threat to the "trustworthiness, utility, and value of science and medicine," according to one of the country's leading medical ethicists.
Arthur L. Caplan, PhD, director of the Division of Medical Ethics in the Department of Population Health at NYU Langone Medical Center, shares these and other observations in a commentary publishing April 3 in the journal Mayo Clinic Proceedings.
"The pollution of science and medicine by plagiarism, ...
2015-04-03
Deaths within 30 days of children's heart surgery have almost halved in the UK over the past decade, despite a rise in the number and complexity of cases during that period, reveals an analysis of national data, published in the online journal Open Heart.
The findings prompt the researchers to suggest that it is now time to shift the focus to longer term survival and other issues that matter greatly to patients and their families, such as measures of ill health and impact on functional capacity.
Children's heart surgery in the UK has come under intense public scrutiny ...
2015-04-03
Passive exposure to bleach in the home is linked to higher rates of childhood respiratory and other infections, suggests research published online in Occupational & Environmental Medicine.
Although modest, the results are of public health concern in light of the widespread use of bleach in the home, say the researchers, who call for further more detailed studies in this area.
The researchers looked at the potential impact of exposure to bleach in the home among more than 9000 children between the ages of 6 and 12 attending 19 schools in Utrecht, The Netherlands; 17 ...
2015-04-03
Highlights
High parathyroid hormone levels and subsequent bone loss are major risk factors for worsening of coronary artery calcification in patients on dialysis.
Washington, DC (April 2, 2015) -- Bone loss may be a sign of poor heart health in patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Monitoring bone loss in dialysis patients may therefore provide an early alert to physicians concerning cardiovascular problems.
Most patients with chronic kidney disease who are on dialysis ...
2015-04-03
Using archival data from the Japan-led Suzaku X-ray satellite, astronomers have determined the pre-explosion mass of a white dwarf star that blew up thousands of years ago. The measurement strongly suggests the explosion involved only a single white dwarf, ruling out a well-established alternative scenario involving a pair of merging white dwarfs.
"Mounting evidence indicates both of these mechanisms produce what we call type Ia supernovae," said lead researcher Hiroya Yamaguchi, an astrophysicist at NASA's Goddard Space Flight Center in Greenbelt, Maryland. "To understand ...
LAST 30 PRESS RELEASES:
[Press-News.org] Possible progress against Parkinson's and good news for stem cell therapies
Mitomycin-treated embryonic stem cells shows to be a safe and effective therapeutic strategy for Parkinson's disease, reducing symptoms and not generating tumors in mice
